How to buy McKesson Corporation (MCK) shares in Australia
Learn how to easily invest in McKesson Corporation shares.
McKesson Corporation (MCK) is a leading medical distribution business with stocks listed in the US. It opened the day at US$472.46 after a previous close of US$470.56. During the day the price has varied from a low of USD464.32 to a high of USD476.3493. The latest price was USD464.65 (25 minute delay). McKesson Corporation is listed on the NYSE. All prices are listed in US Dollars.
How to buy shares in McKesson Corporation
- Compare share trading platforms. To buy shares in a company listed in the US from Australia you'll need to find a trading platform that offers access to US stock markets. Look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, which will typically include your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for McKesson Corporation. Find the share by name or ticker symbol: MCK. Research its history to confirm it's a solid investment that matches your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until McKesson Corporation reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying using consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$470.56, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of McKesson Corporation, depending on your broker.
- Check in on your investment. Congratulations, you own a part of McKesson Corporation. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights.
What's in this guide?
- McKesson Corporation key stats
- Compare share trading platforms
- Is McKesson Corporation stock a buy or sell?
- McKesson Corporation performance over time
- Is McKesson Corporation suitable for ethical investing?
- Are McKesson Corporation shares over-valued?
- McKesson Corporation's financials
- How volatile are McKesson Corporation shares?
- Does McKesson Corporation pay a dividend?
- Have McKesson Corporation shares ever split?
- Other common questions
McKesson Corporation stock price (NYSE:MCK)Use our graph to track the performance of MCK stocks over time.
Have McKesson Corporation's shares ever split?
McKesson Corporation's shares were split on a 2:1 basis on 5 January 1998. So if you had owned 1 share the day before the split, the next day you would own 2 shares. This wouldn't directly have changed the overall worth of your McKesson Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for McKesson Corporation shares which in turn could have impacted McKesson Corporation's share price.
McKesson Corporation shares at a glance
|52-week range||US$330.7966 - US$473.18|
|50-day moving average||US$450.0064|
|200-day moving average||US$403.4804|
|Dividend yield||US$2.24 (0.54%)|
|Earnings per share (TTM)||US$25.28|
McKesson Corporation price performance over time
|1 week (2023-11-22)||1.57%|
|1 month (2023-11-02)||3.81%|
|3 months (2023-09-01)||12.69%|
|6 months (2023-06-02)||19.09%|
|1 year (2022-12-02)||20.11%|
|2 years (2021-12-02)||110.81%|
|3 years (2020-12-03)||159.35%|
|5 years (2018-12-03)||265.41%|
Compare trading platforms to buy McKesson Corporation shares
Is it a good time to buy McKesson Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Is McKesson Corporation under- or over-valued?
Valuing McKesson Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of McKesson Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
McKesson Corporation's P/E ratio
McKesson Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 18x. In other words, McKesson Corporation shares trade at around 18x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
McKesson Corporation's PEG ratio
McKesson Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.6173. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into McKesson Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
McKesson Corporation's EBITDA
McKesson Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$4.9 billion (£3.9 billion).
The EBITDA is a measure of a McKesson Corporation's overall financial performance and is widely used to measure a its profitability.
McKesson Corporation share price volatility
Over the last 12 months, McKesson Corporation's shares have ranged in value from as little as US$330.7966 up to US$473.18. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (NYSE average) beta is 1, while McKesson Corporation's is 0.555. This would suggest that McKesson Corporation's shares are less volatile than average (for this exchange).
McKesson Corporation financials
|Revenue TTM||US$291.1 billion|
|Operating margin TTM||1.27%|
|Gross profit TTM||US$12.4 billion|
|Return on assets TTM||4.23%|
|Return on equity TTM||0%|
|Market capitalisation||US$61.4 billion|
TTM: trailing 12 months
McKesson Corporation share dividends
Dividend payout ratio: 8.41% of net profits
Recently McKesson Corporation has paid out, on average, around 8.41% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.54% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), McKesson Corporation shareholders could enjoy a 0.54% return on their shares, in the form of dividend payments. In McKesson Corporation's case, that would currently equate to about $2.24 per share.
While McKesson Corporation's payout ratio might seem low, this can signify that McKesson Corporation is investing more in its future growth.
McKesson Corporation's most recent dividend payout was on 2 January 2024. The latest dividend was paid out to all shareholders who bought their shares by 30 November 2023 (the "ex-dividend date").
McKesson Corporation's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like McKesson Corporation.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
McKesson Corporation's total ESG risk score
Total ESG risk: 23.8
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and McKesson Corporation's overall score of 23.8 (as at 01/01/2019) is pretty good – landing it in it in the 26th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like McKesson Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
McKesson Corporation's environmental score
Environmental score: 9.12/100
McKesson Corporation's environmental score of 9.12 puts it squarely in the 8th percentile of companies rated in the same sector. This could suggest that McKesson Corporation is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
McKesson Corporation's social score
Social score: 17.15/100
McKesson Corporation's social score of 17.15 puts it squarely in the 8th percentile of companies rated in the same sector. This could suggest that McKesson Corporation is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
McKesson Corporation's governance score
Governance score: 12.53/100
McKesson Corporation's governance score puts it squarely in the 8th percentile of companies rated in the same sector. That could suggest that McKesson Corporation is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
McKesson Corporation's controversy score
Controversy score: 4/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. McKesson Corporation scored a 4 out of 5 for controversy – the second-lowest score possible, reflecting that McKesson Corporation has a damaged public profile.
Environmental, social, and governance (ESG) summary
|Total ESG score||23.8|
|Total ESG percentile||26.02|
|Environmental score percentile||8|
|Social score percentile||8|
|Governance score percentile||8|
|Level of controversy||4|
McKesson Corporation overview
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Stocks similar to McKesson Corporation
Frequently asked questions
More guides on Finder
How to buy OpenAI stock in Australia
Looking to jump on the AI bandwagon? Here's how you can invest in ChatGPT and its parent company OpenAI from Australia.
Best performing stocks on the ASX in 2023 (Updated weekly)
Looking for the best performing stocks in Australia? We update this list weekly.
Cryptocurrency ETFs explained: A simple guide for investors (2023)
If you’re looking for ways to gain exposure to Bitcoin and other digital currencies, cryptocurrency ETFs could be worth exploring. Find out what crypto ETFs are and how they work in this introductory guide.
How to buy Gol Linhas Aereas Inteligentes SA ADR (GOL) shares in Australia
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
How to buy Microsoft (MSFT) shares in Australia
Steps to owning and managing Microsoft shares from in Australia.
A beginner’s guide to Lego investing
Looking for alternative investments? With a ROI of up to 3,593% lego may be worth considering. Read on to find out which lego sets are worth the investment.
The cheapest stock brokers in Australia (Dec 2023)
Find cheap stock brokerage in Australia when buying and selling shares on the ASX and other international exchanges.
What is the money market?
Learn about the money market and everyday consumer money market products.
Is investing in crowdfunding a safe investment?
Equity crowdfunding offers a unique opportunity for investors and for Australian startups, but Australia’s regulatory framework surrounding crowdfunding still lags behind the rest of the world.
The best trading platforms in Australia for 2023
Follow these tips to find the best share trading platform for you.
Ask an Expert